Related Experiment Video
Updated: Aug 13, 2025

Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors-A Pan-Cancer Machine Learning Workflow for
André Marquardt1, Philipp Hartrampf2, Philip Kollmannsberger3
1Department of Pathology, Klinikum Stuttgart, 70174 Stuttgart, Germany.
Abstract:
(1) Background: C-X-C Motif Chemokine Receptor 4 (CXCR4) and Fibroblast Activation Protein Alpha (FAP) are promising theranostic targets. However, it is unclear whether CXCR4 and FAP positivity mark distinct microenvironments, especially in solid tumors. (2) Methods: Using Random Forest (RF) analysis, we searched for entity-independent mRNA and microRNA signatures related to CXCR4 and FAP overexpression in our pan-cancer cohort from The Cancer Genome Atlas (TCGA) database-representing n = 9242 specimens from 29 tumor entities. CXCR4- and FAP-positive samples were assessed via StringDB cluster analysis, EnrichR, Metascape, and Gene Set Enrichment Analysis (GSEA). Findings were validated via correlation analyses in n = 1541 tumor samples. TIMER2.0 analyzed the association of CXCR4 / FAP expression and infiltration levels of immune-related cells. (3) Results: We identified entity-independent CXCR4 and FAP gene signatures representative for the majority of solid cancers. While CXCR4 positivity marked an immune-related microenvironment, FAP overexpression highlighted an angiogenesis-associated niche. TIMER2.0 analysis confirmed characteristic infiltration levels of CD8+ cells for CXCR4-positive tumors and endothelial cells for FAP-positive tumors. (4) Conclusions: CXCR4- and FAP-directed PET imaging could provide a non-invasive decision aid for entity-agnostic treatment of microenvironment in solid malignancies. Moreover, this machine learning workflow can easily be transferred towards other theranostic targets.
Insights
C-X-C Motif Chemokine Receptor 4 (CXCR4) and Fibroblast Activation Protein Alpha (FAP) target distinct tumor microenvironments. CXCR4 positivity indicates an immune-rich niche, while FAP overexpression signals an angiogenic one, aiding theranostic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- C-X-C Motif Chemokine Receptor 4 (CXCR4) and Fibroblast Activation Protein Alpha (FAP) are emerging as key theranostic targets in oncology.
- The distinct roles of CXCR4 and FAP in defining tumor microenvironments, particularly in solid tumors, remain inadequately understood.
Purpose of the Study:
- To investigate whether CXCR4 and FAP positivity delineate separate microenvironmental niches across various solid cancers.
- To identify entity-independent molecular signatures associated with CXCR4 and FAP overexpression.
Main Methods:
- Utilized Random Forest (RF) analysis on The Cancer Genome Atlas (TCGA) database (n=9242) to identify mRNA and microRNA signatures for CXCR4 and FAP.
- Performed StringDB cluster analysis, EnrichR, Metascape, and Gene Set Enrichment Analysis (GSEA) for functional enrichment.
- Validated findings via correlation analyses (n=1541) and assessed immune cell infiltration using TIMER2.0.
Main Results:
- Identified robust, entity-independent gene signatures for CXCR4 and FAP across most solid cancers.
- CXCR4 overexpression was associated with an immune-related microenvironment, characterized by CD8+ cell infiltration.
- FAP overexpression was linked to an angiogenesis-associated niche, with increased endothelial cell infiltration.
Conclusions:
- CXCR4 and FAP represent distinct theranostic targets, marking separate tumor microenvironmental niches.
- CXCR4- and FAP-directed PET imaging may offer non-invasive decision support for entity-agnostic microenvironment-targeted therapies.
- The developed machine learning workflow is adaptable for other theranostic targets.
More Related Videos
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018